Cytokinetics
CYTK
#2423
Rank
NZ$13.37 B
Marketcap
NZ$96.01
Share price
-3.35%
Change (1 day)
-13.15%
Change (1 year)

EPS for Cytokinetics (CYTK)

EPS in 2023 (TTM): NZ-$9.37

According to Cytokinetics 's latest financial reports the company's current EPS (TTM) is NZ-$12.91. In 2022 the company made an earnings per share (EPS) of NZ-$7.60 a decrease over its 2021 EPS that were of NZ-$5.06.

EPS history for Cytokinetics from 2003 to 2023

Annual EPS

Year EPS Change
2023 (TTM)NZ-$9.3723.27%
2022NZ-$7.6050.18%
2021NZ-$5.0640.8%
2020NZ-$3.59-4.74%
2019NZ-$3.778.21%
2018NZ-$3.49-24.12%
2017NZ-$4.60-776.32%
2016NZ$0.68-139.18%
2015NZ-$1.73125.58%
2014NZ-$0.77-67.67%
2013NZ-$2.38-44.58%
2012NZ-$4.29-44.95%
2011NZ-$7.80-6.84%
2010NZ-$8.37-290.24%
2009NZ$4.40-135.96%
2008NZ-$12.2310.68%
2007NZ-$11.05-33.97%
2006NZ-$16.745.41%
2005NZ-$15.88-60.64%
2004NZ-$40.34-77.21%
2003NZ-$177.03

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amgen
AMGN
NZ$29.00-324.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
NZ-$62.12 381.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$17.90-238.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
NZ-$89.96 596.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
NZ-$1.75-86.43%๐Ÿ‡บ๐Ÿ‡ธ USA